Yair Lotan, MD: Biomarker Developed From Computational Histology AI Platform Guides Risk Stratification in MIBC

Yair Lotan, MD, of UT Southwestern Medical Center, discusses the validation of a novel prognostic biomarker, developed using the computational histology AI (CHAI) platform, to stratify patients with muscle-invasive bladder cancer according to their risk for recurrence and survival. Findings supporting the utility of the biomarker were presented at the 2026 ASCO Genitourinary Cancers Symposium (Abstract 791).